Group One Trading, L.P. Tango Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
A detailed history of Group One Trading, L.P. transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 1,400 shares of TNGX stock, worth $9,674. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,400Holding current value
$9,674% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
117MCall Options Held
245KPut Options Held
18.9K-
Trv Gp Iv, LLC Boston, MA16.9MShares$116 Million97.21% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$74.2 Million11.21% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$73.5 Million4.69% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.16MShares$63.3 Million0.21% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$41.7 Million0.18% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $609M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...